Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06309953 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
A Phase 4 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
NCT06309953 is a Phase 4 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 99 participants.
The verdict
NCT06309953, a Phase 4 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
Study Summary
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Interventions
- DRUG Miebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2024-06-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06309953
The ClinicalTrials.gov registry entry for NCT06309953 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Miebo is the first listed.
NCT06309953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06309953 about?
NCT06309953 is a clinical study titled "A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease". An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
What is the current status of trial NCT06309953?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2024-02-28. Estimated completion is 2024-06-17.
What interventions are being tested in trial NCT06309953?
The interventions under investigation include: Miebo (DRUG).
Who is sponsoring clinical trial NCT06309953?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.